Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Colorectal Cancer · CRC · Pancreatic Ductal Adenocarcinoma · PDAC · Gastrointestinal Cancer · Metastatic Pancreatic Ductal Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Ironwood Cancer and Research Centers, Chandler, Arizona, United States
Contact: Study coordinator (Research Department) · research@ironwoodcrc.com · 480-398-7671
Mayo Clinic Hospital, Phoenix, Arizona, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
HonorHealth Research Institute, Scottsdale, Arizona, United States
Contact: Study coordinator (Andrea House) · ahouse@honorhealth.com · 480-323-1364
UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Study coordinator (Andrea Galfo) · agalfo@health.com · 858-822-4500
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Naomi Geier) · naomi.geier@cshs.org · 310-423-4693
UCLA Hematology/Oncology- Santa Monica, Los Angeles, California, United States
Contact: Study coordinator (Jenna Davis) · jldavis@mednet.ucla.edu · (310) 633-8400
University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora, Colorado, United States
Contact: Study coordinator (Emily Harper) · Emily.harper@cuanschutz.edu · (303) 724-9407
Yale-New Haven Hospital-Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Stefanie Diaz) · Stefanie.Diaz@yale.edu · 475-227-1088
Contact: Study coordinator (Kwasi Boateng) · Kwasi.Boateng@yale.edu · 203-314-7948
Mayo Clinic Cancer Center, Jacksonville, Florida, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Nilufar Aliyeva) · Nilufar.Aliyeva@moffitt.org · 813.745.4436
The University of Kansas Clinical Research Center, Westwood, Kansas, United States
Study coordinator · CTNurseNav@kumc.edu · 913-945-7552
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Colleen Apostol) · giclinicaltrials@jhmi.edu · 410-614-3644
Contact: Study coordinator (Joann Santmyer) · giclinicaltrials@jhmi.edu · 410-614-3644
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Aparna Parikh) · Aparna.Parikh@MGH.HARVARD.EDU · (617) 724-4000
Contact: Study coordinator (Bennett Caughey) · bcaughey1@mgb.org · (617) 724-4000
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Charlotte Healy) · charlotte_healy@dfci.harvard.edu · 617-632-5728
Mayo Clinic, Rochester, Minnesota, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Study coordinator (Ashley Servais) · aservais@nebraskacancer.com · 4029552691
Contact: Study coordinator (Evan Roberts) · eroberts@nebraskacancer.com · 4023344773
University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (Mahdi Hassan) · mhassan@unmc.edu · 402-559-1947
Contact: Study coordinator (Monica Davis) · mondavis@unmc.edu · 402-559-9466
Atlantic Health System, Morristown, New Jersey, United States
Contact: Study coordinator (Salome Geene) · salome.geene@atlantichelath.org · 973-971-6373
Contact: Study coordinator (Tracey Hilden) · tracey.hilden@atlantichealth.org · 973-971-7889
Northwell Health / RJ Zuckerberg Cancer Center, Lake Success, New York, United States
Contact: Study coordinator (Deeksha Kaura) · GITrialReferral@northwell.edu · 516-734-8906
Columbia University Medical Center, New York, New York, United States
Study coordinator · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
Memorial Sloan Kettering Cancer Center Main Campus, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Brooke Currier) · grayson.currier@duke.edu · (919) 681-3933
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Study coordinator · cancer@uchealth.com · 513-584-7698
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Christina Caldwell) · Christina-Caldwell@ouhsc.edu · 405-271-8001
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Jimar Hill) · Jimar.Hill@pennmedicine.upenn.edu · 215 349 8245
SCRI Oncology Partners, Nashville, Tennessee, United States
Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Henry Atencio) · Henry.VillalobosAtencio@bcm.edu · 713-798-3743
Contact: Study coordinator (Glenn Wilson) · ggwilson@bcm.edu · 713-798-3468
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study coordinator · GIClinicalTrials@mdanderson.org
NEXT Oncology Dallas, Irving, Texas, United States
Contact: Study coordinator (Idara Ukpong) · iukpong@nextoncology.com · 972.893.8800
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Susan Sharry) · (Susan.Sharry@hci.utah.edu) · (801) 585-3453
Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Study coordinator (Karina Castillo) · Karina.CastilloGrady@usoncology.com · 571.350.8758
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Matt Sherman) · mfsherman@fredhutch.org · 206-606-6347

מובילי המחקר

Study Director
Revolution Medicines

צפייה במקור ב־ClinicalTrials.gov פנייה לחוקר (אימייל)